3.22.2.2 html 170 168 1 false 49 0 false 6 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.acurxpharma.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONDENSED INTERIM BALANCE SHEETS Sheet http://www.acurxpharma.com/role/StatementCondensedInterimBalanceSheets CONDENSED INTERIM BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONDENSED INTERIM BALANCE SHEETS (Parenthetical) Sheet http://www.acurxpharma.com/role/StatementCondensedInterimBalanceSheetsParenthetical CONDENSED INTERIM BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONDENSED INTERIM STATEMENTS OF OPERATIONS Sheet http://www.acurxpharma.com/role/StatementCondensedInterimStatementsOfOperations CONDENSED INTERIM STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00300 - Statement - CONDENSED INTERIM STATEMENTS OF CHANGES IN MEMBERS' AND SHAREHOLDERS' EQUITY Sheet http://www.acurxpharma.com/role/StatementCondensedInterimStatementsOfChangesInMembersAndShareholdersEquity CONDENSED INTERIM STATEMENTS OF CHANGES IN MEMBERS' AND SHAREHOLDERS' EQUITY Statements 5 false false R6.htm 00305 - Statement - CONDENSED INTERIM STATEMENTS OF CHANGES IN MEMBERS' AND SHAREHOLDERS' EQUITY (Parenthetical) Sheet http://www.acurxpharma.com/role/StatementCondensedInterimStatementsOfChangesInMembersAndShareholdersEquityParenthetical CONDENSED INTERIM STATEMENTS OF CHANGES IN MEMBERS' AND SHAREHOLDERS' EQUITY (Parenthetical) Statements 6 false false R7.htm 00400 - Statement - CONDENSED INTERIM STATEMENTS OF CASH FLOWS Sheet http://www.acurxpharma.com/role/StatementCondensedInterimStatementsOfCashFlows CONDENSED INTERIM STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 10101 - Disclosure - NATURE OF OPERATIONS Sheet http://www.acurxpharma.com/role/DisclosureNatureOfOperations NATURE OF OPERATIONS Notes 8 false false R9.htm 10201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.acurxpharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 10301 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES Sheet http://www.acurxpharma.com/role/DisclosureAccountsPayableAndAccruedExpenses ACCOUNTS PAYABLE AND ACCRUED EXPENSES Notes 10 false false R11.htm 10401 - Disclosure - EXECUTIVE COMPENSATION Sheet http://www.acurxpharma.com/role/DisclosureExecutiveCompensation EXECUTIVE COMPENSATION Notes 11 false false R12.htm 10501 - Disclosure - ISSUANCE OF EQUITY INTERESTS Sheet http://www.acurxpharma.com/role/DisclosureIssuanceOfEquityInterests ISSUANCE OF EQUITY INTERESTS Notes 12 false false R13.htm 10601 - Disclosure - SHARE-BASED COMPENSATION Sheet http://www.acurxpharma.com/role/DisclosureShareBasedCompensation SHARE-BASED COMPENSATION Notes 13 false false R14.htm 10701 - Disclosure - SHARE-BASED PAYMENTS TO VENDORS Sheet http://www.acurxpharma.com/role/DisclosureShareBasedPaymentsToVendors SHARE-BASED PAYMENTS TO VENDORS Notes 14 false false R15.htm 10801 - Disclosure - NET LOSS PER SHARE Sheet http://www.acurxpharma.com/role/DisclosureNetLossPerShare NET LOSS PER SHARE Notes 15 false false R16.htm 10901 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.acurxpharma.com/role/DisclosureCommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 16 false false R17.htm 20202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.acurxpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 17 false false R18.htm 30303 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) Sheet http://www.acurxpharma.com/role/DisclosureAccountsPayableAndAccruedExpensesTables ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) Tables http://www.acurxpharma.com/role/DisclosureAccountsPayableAndAccruedExpenses 18 false false R19.htm 30503 - Disclosure - ISSUANCE OF EQUITY INTERESTS (Tables) Sheet http://www.acurxpharma.com/role/DisclosureIssuanceOfEquityInterestsTables ISSUANCE OF EQUITY INTERESTS (Tables) Tables http://www.acurxpharma.com/role/DisclosureIssuanceOfEquityInterests 19 false false R20.htm 30603 - Disclosure - SHARE-BASED COMPENSATION (Tables) Sheet http://www.acurxpharma.com/role/DisclosureShareBasedCompensationTables SHARE-BASED COMPENSATION (Tables) Tables http://www.acurxpharma.com/role/DisclosureShareBasedCompensation 20 false false R21.htm 40101 - Disclosure - NATURE OF OPERATIONS (Details) Sheet http://www.acurxpharma.com/role/DisclosureNatureOfOperationsDetails NATURE OF OPERATIONS (Details) Details http://www.acurxpharma.com/role/DisclosureNatureOfOperations 21 false false R22.htm 40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.acurxpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.acurxpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies 22 false false R23.htm 40202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration (Details) Sheet http://www.acurxpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesConcentrationDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration (Details) Details 23 false false R24.htm 40301 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) Sheet http://www.acurxpharma.com/role/DisclosureAccountsPayableAndAccruedExpensesDetails ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) Details http://www.acurxpharma.com/role/DisclosureAccountsPayableAndAccruedExpensesTables 24 false false R25.htm 40401 - Disclosure - EXECUTIVE COMPENSATION (Details) Sheet http://www.acurxpharma.com/role/DisclosureExecutiveCompensationDetails EXECUTIVE COMPENSATION (Details) Details http://www.acurxpharma.com/role/DisclosureExecutiveCompensation 25 false false R26.htm 40501 - Disclosure - ISSUANCE OF EQUITY INTERESTS (Details) Sheet http://www.acurxpharma.com/role/DisclosureIssuanceOfEquityInterestsDetails ISSUANCE OF EQUITY INTERESTS (Details) Details http://www.acurxpharma.com/role/DisclosureIssuanceOfEquityInterestsTables 26 false false R27.htm 40502 - Disclosure - ISSUANCE OF EQUITY INTERESTS - Fair Value (Details) Sheet http://www.acurxpharma.com/role/DisclosureIssuanceOfEquityInterestsFairValueDetails ISSUANCE OF EQUITY INTERESTS - Fair Value (Details) Details 27 false false R28.htm 40503 - Disclosure - ISSUANCE OF EQUITY INTERESTS - Outstanding warrants (Details) Sheet http://www.acurxpharma.com/role/DisclosureIssuanceOfEquityInterestsOutstandingWarrantsDetails ISSUANCE OF EQUITY INTERESTS - Outstanding warrants (Details) Details 28 false false R29.htm 40601 - Disclosure - SHARE-BASED COMPENSATION - (Details) Sheet http://www.acurxpharma.com/role/DisclosureShareBasedCompensationDetails SHARE-BASED COMPENSATION - (Details) Details http://www.acurxpharma.com/role/DisclosureShareBasedCompensationTables 29 false false R30.htm 40602 - Disclosure - SHARE-BASED COMPENSATION - Option pricing (Details) Sheet http://www.acurxpharma.com/role/DisclosureShareBasedCompensationOptionPricingDetails SHARE-BASED COMPENSATION - Option pricing (Details) Details 30 false false R31.htm 40603 - Disclosure - SHARE-BASED COMPENSATION - Stock option activity (Details) Sheet http://www.acurxpharma.com/role/DisclosureShareBasedCompensationStockOptionActivityDetails SHARE-BASED COMPENSATION - Stock option activity (Details) Details 31 false false R32.htm 40701 - Disclosure - SHARE-BASED PAYMENTS TO VENDORS (Details) Sheet http://www.acurxpharma.com/role/DisclosureShareBasedPaymentsToVendorsDetails SHARE-BASED PAYMENTS TO VENDORS (Details) Details http://www.acurxpharma.com/role/DisclosureShareBasedPaymentsToVendors 32 false false R33.htm 40801 - Disclosure - NET LOSS PER SHARE (Details) Sheet http://www.acurxpharma.com/role/DisclosureNetLossPerShareDetails NET LOSS PER SHARE (Details) Details http://www.acurxpharma.com/role/DisclosureNetLossPerShare 33 false false R34.htm 40901 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://www.acurxpharma.com/role/DisclosureCommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://www.acurxpharma.com/role/DisclosureCommitmentsAndContingencies 34 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 23 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:EarningsPerShareBasic, us-gaap:EarningsPerShareDiluted, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage, us-gaap:WarrantsAndRightsOutstandingMeasurementInput, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding, us-gaap:WeightedAverageNumberOfSharesOutstandingBasic - acxp-20220930x10q.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies - acxp-20220930x10q.htm 9 acxp-20220930x10q.htm acxp-20220930.xsd acxp-20220930_cal.xml acxp-20220930_def.xml acxp-20220930_lab.xml acxp-20220930_pre.xml acxp-20220930xex31d1.htm acxp-20220930xex31d2.htm acxp-20220930xex32d1.htm acxp-20220930xex32d2.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true